Related Experiment Video
Updated: Oct 14, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Guidelines for Prevention and Treatment of Chronic Hepatitis B
Guiqiang Wang1, Zhongping Duan2
1Center for Liver Diseases, Department of Infectious Diseases, Peking University First Hospital; Department of Infectious and Liver Diseases, Peking University International Hospital, Beijing, China.
Insights
Updated Chinese guidelines for chronic hepatitis B (CHB) aim to eliminate viral hepatitis by 2030. These guidelines incorporate recent research and China's specific context for prevention, diagnosis, and treatment.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Viral hepatitis remains a significant global public health threat.
- The World Health Organization has set a goal to eliminate viral hepatitis by 2030.
- China faces specific challenges in managing chronic hepatitis B (CHB).
Purpose of the Study:
- To update the national guidelines for the prevention and treatment of chronic hepatitis B (CHB).
- To align with global efforts to eliminate viral hepatitis.
- To provide evidence-based recommendations tailored to China's healthcare landscape.
Main Methods:
- Convening an expert panel by the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology in 2019.
- Reviewing recent advances in basic, clinical, and preventive research on CHB.
- Considering the epidemiological and clinical situation specific to China.
Main Results:
- The updated guidelines encompass the latest scientific findings in CHB.
- Recommendations are contextualized for the Chinese population and healthcare system.
- The guidelines provide a comprehensive framework for managing CHB.
Conclusions:
- The updated guidelines serve as a crucial resource for healthcare professionals in China.
- Implementation of these guidelines is expected to support the national strategy against CHB.
- These recommendations contribute to the global goal of viral hepatitis elimination.
Abstract:
To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology convened an expert panel in 2019 to update the guidelines for the prevention and treatment of chronic hepatitis B (CHB). The current guidelines cover recent advances in basic, clinical, and preventive studies of CHB infection and consider the actual situation in China. These guidelines are intended to provide support for the prevention, diagnosis, and treatment of CHB.
Related Concept Videos
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Chronic Pancreatitis II: Collaborative Care
Assessment:

